Supraflex Cruz evidence presented at TCT 2025
In November 2025, EUKON shared an update from Sahajanand Medical…
EUKON receives the PulseCath 2026 Innovation Partner Award
EUKON received the PulseCath Awards 2026 Innovation Partner Award ahead of EuroPCR in Paris.
The award recognises our contribution to innovation and our commitment to supporting advanced cardiovascular technologies. It marks a milestone in the collaboration between EUKON and PulseCath and in our work alongside physicians and healthcare institutions.
We thank PulseCath, Oren Malchin and the EUKON team for this recognition and their continued commitment.
Announcement: May 2026.
Latest News:
LaaGuarder: first European clinical use announced by EUKON
In January 2026, EUKON announced the first clinical use in…
Supraflex Cruz NEVO now available to Italian cath labs
EUKON announced the availability of Supraflex Cruz NEVO to Italian…